Clinical Trial Update: Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating loteprednol etabonate ophthalmic suspension for the treatment of dry eye.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• Loteprednol etabonate ophthalmic suspension (Loteprednol etabonate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Dry Eye | Phase 2 | Status: COMPLETED